Have a personal or library account? Click to login
Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience Cover

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience

Radiology and Oncology
Volume 49 (2015): Issue 1 (March 2015)
By: Tanja Mesti,  Maja Ebert Moltara,  Marko Boc,  Martina Rebersek and  Janja Ocvirk  
Open Access
|Mar 2015

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/raon-2014-0021 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 80 - 85
Submitted on: Sep 9, 2013
|
Accepted on: Nov 8, 2013
|
Published on: Mar 3, 2015
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
recurrent malignant glioma,
bevacizumab,
irinotecan,
systemic therapy
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2015 Tanja Mesti, Maja Ebert Moltara, Marko Boc, Martina Rebersek, Janja Ocvirk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 49 (2015): Issue 1 (March 2015)Next article